Introduction of mutations into the non-structural genes or 3′ untranslated region of an attenuated dengue virus type 4 vaccine candidate further decreases replication in rhesus monkeys while retaining protective immunity

This publication has 41 references indexed in Scilit:

• Substitution of the structural genes of dengue virus type 4 with those of type 2 results in chimeric vaccine candidates which are attenuated for mosquitoes, mice, and rhesus monkeys
  Vaccine, 2003
• A Live, Attenuated Dengue Virus Type 1 Vaccine Candidate with a 30-Nucleotide Deletion in the 3′ Untranslated Region Is Highly Attenuated and Immunogenic in Monkeys
  Journal of Virology, 2003
• Human Arbovirus Infections Worldwide
  Annals of the New York Academy of Sciences, 2001
• Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region.
  The American Journal of Tropical Medicine and Hygiene, 2001
• Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers
  Vaccine, 2001
• Prospective study of the duration and magnitude of viraemia in children hospitalised during the 1996-1997 dengue-2 outbreak in French Polynesia
  Journal of Medical Virology, 2000
• Dengue Viremia Titer, Antibody Response Pattern, and Virus Serotype Correlate with Disease Severity
  The Journal of Infectious Diseases, 2000
• Dengue and Dengue Hemorrhagic Fever
  Clinical Microbiology Reviews, 1998
• Testing of a dengue 2 live-attenuated vaccine (strain 16681 PDK 53) in ten American volunteers
  Vaccine, 1996
• Selection of Attenuated Dengue 4 Viruses by Serial Passage in Primary Kidney Cells
  The American Journal of Tropical Medicine and Hygiene, 1984